SOURCE: Oncologix Tech, Inc.

Oncologix Tech, Inc.

October 20, 2015 12:59 ET

Oncologix Launches New Company Website OCLGHealth.com

NEW ORLEANS, LA--(Marketwired - Oct 20, 2015) - Oncologix Tech Inc. (OTC PINK: OCLG), a fully reporting, diversified medical holding company with operating units in advanced medical products and technologies, healthcare services, and medical product distributions, announced the launch of its new website www.OCLGHealth.com.

The new website, designed and developed by Proclaim Interactive, focuses on providing information on the company's parent-level operations and all wholly-owned subsidiaries, updating all stakeholders on upcoming business activities, displaying real-time stock information, and a public communications forum.

"We are ecstatic to launch Oncologix's new website for the world to see," said Nikole Jessie, Director of Marketing and Public Relations for OCLG. "Our valued clients and shareholders will have an informative experience as we expand and grow our company. We are excited to introduce a monthly executive management newsletter, which will be added to the website in the weeks to follow. From a public relations/marketing perspective, the website allows our management team an opportunity to communicate with our customers, investors, shareholders, employees and affiliates more effectively on current and future business activities at OCLG."

The Oncologix website will be updated on a regular basis with news of potential business acquisitions, subsidiary activities, new product launches, corporate milestones, news events, and investor and financial information. The website can also be viewed on smartphones, tablets, and other mobile devices without loss of functionality.

About Oncologix Tech, Inc.
Oncologix operates business units in medical device, healthcare services, and medical products and technologies distribution. For its clients, Oncologix provides FDA approved medical devices, state licensed healthcare services, and broad range medical products and technologies. For its shareholders, Oncologix operates profitable operations that build, maintain and nourish shareholder value. The Company's corporate mission is to be the best small cap medical holding company in North America.

Forward Looking Statement:
This press release may contain forward-looking statements, made in reliance upon Section 21D of the Exchange Act of 1934, which involve known and unknown risks, uncertainties or other factors that could cause actual results to differ materially from the results, performance, or expectations implied by these forward-looking statements. The Company's expectations, among other things, are dependent upon economic conditions, continued demand for its products, the availability of raw materials, retention of its key management and operating personnel, its ability to operate its subsidiary companies effectively, need for and availability of more capital as well as other uncontrollable or unknown factors which are more fully disclosed in the Company's filings with the Securities and Exchange Commission.

Contact Information

  • CONTACT INFORMATION

    Investor Relations:
    Jack Eversull, President
    The Eversull Group
    972-571-1624
    214-469-2361 fax
    Email Contact

    Investor Relations:
    Nikole Jessie
    Director of Marketing and Public Relations
    Email Contact